tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate | CAS:83056-79-5

We serve tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate CAS:83056-79-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate

Chemical Name:     tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate
CAS.NO:  83056-79-5
Synonyms:
4-Imidazolidinecarboxylic acid, 1-methyl-2-oxo-, 1,1-dimethylethyl ester, (4S)-
2-Methyl-2-propanyl (4S)-1-methyl-2-oxo-4-imidazolidinecarboxylate

Molecular Formula: C9H16N2O3
Molecular Weight:  200.23500

Physical and Chemical Properties:
Density: 1.115 g / cm3
Boiling point: 347.4ºC at 760 mmHg
Melting point: /
Flash point: 163.9±24.8 °C
Refractive index: 1.473

Specification:
Appearance:White  Powder
Purity:≥98.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Imidapril CAS:89371-37-9.



Contact us for information like tert-butyl (4S)-1-methyl-2-oxoimidazolidine-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-2-propanyl (4S)-1-methyl-2-oxo-4-imidazolidinecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-2-propanyl (4S)-1-methyl-2-oxo-4-imidazolidinecarboxylate Use and application,2-Methyl-2-propanyl (4S)-1-methyl-2-oxo-4-imidazolidinecarboxylate technical grade,usp/ep/jp grade.


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.4-Chlorobenzyl Chloride manufacturer From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.4-Chlororesorcinol supplier An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.3-(Trifluoromethoxy)aniline vendor An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.